查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589449

皮膚科治療藥物市場：按藥物類別、應用分類 - 全球預測 2025-2030

Dermatological Therapeutics Market by Drug Class (Anti-Acne, Anti-Infectives, Calcineurin Inhibitors), Application (Alopecia, Atopic Dermatitis, Herpes) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年皮膚科治療市場價值為569.9億美元，預計到2024年將達到626.8億美元，複合年成長率為10.38%，到2030年將達到1137.9億美元。

皮膚科治療市場涵蓋各種旨在解決皮膚相關健康問題的治療方法和產品，從痤瘡和乾癬等常見疾病到黑色素瘤等嚴重。由於皮膚病的增加、環境變化和生活方式因素刺激的護膚和治療選擇意識的提高，該細分市場是必要的。皮膚科治療應用包括局部治療、全身治療以及生技藥品和基因治療等先進治療，主要最終用戶是醫療中心、皮膚科診所和研究機構。主要成長要素包括醫療保健支出增加、技術創新增加以及對美容增強手術的強勁需求。個人化醫療和基因研究的興起為治療罕見和嚴重皮膚病開闢了潛在機會，對該領域的投資可以產生豐厚的回報。為了抓住這些機會，公司應專注於需求未滿足的新興市場，並投資於創新藥物開發技術。但由於研發成本上升、法規環境嚴格、學名藥競爭等挑戰，該藥仍有其限制。公司還必須克服與新療法相關的專利懸崖和潛在副作用。最有希望創新的領域包括生物療法、遠距皮膚病學的進步以及個人化診斷和治療的人工智慧。市場是動態的，其特點是技術進步和消費者期望驅動的激烈競爭和快速變化。專注於具有治療和美容功效的多功能藥物的研發與滿足皮膚健康和美容需求的產品需求相一致，代表了一條成長之路。尋求保持競爭力的公司也應該考慮策略聯盟和收購，以加強其產品組合和市場覆蓋範圍。透過駕馭這些動態，皮膚病治療市場的相關人員可以利用創新和未滿足的臨床需求來有效刺激業務成長。

主要市場統計
基準年[2023] 569.9億美元
預測年份 [2024] 626.8億美元
預測年份 [2030] 1137.9億美元
複合年成長率（%） 10.38%

市場動態：揭示快速發展的皮膚科治療市場的關鍵市場洞察

供需的動態交互作用正在改變皮膚科治療市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 皮膚病盛行率增加
    • 醫療費用增加和對皮膚病的認知提高
    • 對同類療法皮膚病治療的需求增加
  • 市場限制因素
    • 皮膚科治療費用比較高
  • 市場機會
    • 開發下一代皮膚癌治療方法
    • 皮膚科治療的研究、開發與技術創新
  • 市場問題
    • 某些治療類別的副作用

波特五力：駕馭皮膚科藥物市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解皮膚科藥物市場的外部影響

外部宏觀環境因素在塑造皮膚科治療市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解皮膚科治療市場的競爭格局

皮膚病治療市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：皮膚科治療市場供應商的績效評估

FPNV定位矩陣是評估皮膚科治療市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製皮膚病治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，皮膚病治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 市場促進因素
      • 皮膚病盛行率增加
      • 醫療費用增加和對皮膚病的認知提高
      • 對同類療法皮膚病治療的需求增加
    • 抑制因素
      • 皮膚科治療費用比較高
    • 市場機會
      • 開發下一代皮膚癌治療方法
      • 皮膚醫學研究、開發與技術創新
    • 市場問題
      • 某些治療類別的副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章皮膚科藥物市場：依藥物類別

  • 介紹
  • 預防痤瘡
  • 抗感染
  • Calcineurin抑制劑
  • 皮質類固醇
  • 類視色素A

第7章皮膚科治療藥物市場：依應用分類

  • 介紹
  • 脫髮症
  • 異位性皮膚炎
  • 皰疹
  • 乾癬
  • 酒糟樣皮膚炎

第8章北美和南美皮膚科藥物市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太皮膚科藥物市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲皮膚科藥物市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Aclaris Therapeutics Inc.
  • Allergan PLC by AbbVie Inc.
  • Almirall, LLC
  • Amgen Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Galderma Laboratories, LP
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services Inc.
  • Leo Pharma A/S
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries, Inc.
Product Code: MRR-742BD517D23A

The Dermatological Therapeutics Market was valued at USD 56.99 billion in 2023, expected to reach USD 62.68 billion in 2024, and is projected to grow at a CAGR of 10.38%, to USD 113.79 billion by 2030.

The dermatological therapeutics market encompasses a broad spectrum of treatments and products aimed at addressing skin-related health issues, ranging from common conditions like acne and psoriasis to severe diseases such as melanoma. This sector is necessitated by rising skin disorders and a growing awareness of skincare and treatment options, spurred by environmental changes and lifestyle factors. Applications of dermatological therapeutics include topical treatments, systemic medications, and advanced therapies like biologics and gene therapies, catering to medical centers, dermatology clinics, and research institutions as primary end-users. Key growth influencers include increased healthcare spending, advancing technological innovations, and a strong demand for aesthetic enhancement procedures. The rise in personalized medicine and genetic research opens potential opportunities for targeting rare and severe dermatological conditions; investment in this area could yield substantial returns. To seize these opportunities, companies should focus on emerging markets with unmet needs and invest in innovative drug development technologies. However, challenges such as high R&D costs, stringent regulatory environments, and competition from generic products pose limitations. Companies must also navigate patent cliffs and potential side effects associated with novel therapies. The most promising areas for innovation include biologic therapeutics, teledermatology advancements, and artificial intelligence in diagnosis and treatment personalization. The market is dynamic, characterized by high competition and rapid changes prompted by technological advancements and consumer expectations. Research and development focused on multifunctional drugs that combine therapeutic and cosmeceutical benefits represent a growth avenue, aligning with demand for products that cater to both dermatological health and aesthetic desires. Companies looking to stay competitive should also consider strategic collaborations or acquisitions to enhance their portfolios and market reach. By navigating these dynamics thoughtfully, stakeholders in the dermatological therapeutics market can leverage innovation and unmet clinical needs to spur business growth effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 56.99 billion
Estimated Year [2024] USD 62.68 billion
Forecast Year [2030] USD 113.79 billion
CAGR (%) 10.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dermatological Therapeutics Market

The Dermatological Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalences of the skin disorders
    • Increasing healthcare expenditure and growing awareness about skin diseases
    • Rising demand for homeopathy dermatology therapeutics
  • Market Restraints
    • Relatively high cost of the dermatology therapeutics
  • Market Opportunities
    • Development of next-generation therapeutics for skin cancer
    • Medical dermatology therapeutic R&D and technical innovation
  • Market Challenges
    • Side effects for certain classes of therapeutic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Dermatological Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dermatological Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dermatological Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dermatological Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dermatological Therapeutics Market

A detailed market share analysis in the Dermatological Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dermatological Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dermatological Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dermatological Therapeutics Market

A strategic analysis of the Dermatological Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dermatological Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Aclaris Therapeutics Inc., Allergan PLC by AbbVie Inc., Almirall, LLC, Amgen Inc., AstraZeneca PLC, Bausch Health Companies Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Galderma Laboratories, L.P., GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Leo Pharma A/S, Merck & Co., Inc., Novartis AG, Pfizer Inc., and Sun Pharmaceutical Industries, Inc..

Market Segmentation & Coverage

This research report categorizes the Dermatological Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Class, market is studied across Anti-Acne, Anti-Infectives, Calcineurin Inhibitors, Corticosteroids, and Retinoids.
  • Based on Application, market is studied across Alopecia, Atopic Dermatitis, Herpes, Psoriasis, and Rosacea.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalences of the skin disorders
      • 5.1.1.2. Increasing healthcare expenditure and growing awareness about skin diseases
      • 5.1.1.3. Rising demand for homeopathy dermatology therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost of the dermatology therapeutics
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of next-generation therapeutics for skin cancer
      • 5.1.3.2. Medical dermatology therapeutic R&D and technical innovation
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects for certain classes of therapeutic drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dermatological Therapeutics Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Anti-Acne
  • 6.3. Anti-Infectives
  • 6.4. Calcineurin Inhibitors
  • 6.5. Corticosteroids
  • 6.6. Retinoids

7. Dermatological Therapeutics Market, by Application

  • 7.1. Introduction
  • 7.2. Alopecia
  • 7.3. Atopic Dermatitis
  • 7.4. Herpes
  • 7.5. Psoriasis
  • 7.6. Rosacea

8. Americas Dermatological Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Dermatological Therapeutics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Dermatological Therapeutics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aclaris Therapeutics Inc.
  • 2. Allergan PLC by AbbVie Inc.
  • 3. Almirall, LLC
  • 4. Amgen Inc.
  • 5. AstraZeneca PLC
  • 6. Bausch Health Companies Inc.
  • 7. Bristol-Myers Squibb Company
  • 8. Eli Lilly and Company
  • 9. Galderma Laboratories, L.P.
  • 10. GlaxoSmithKline PLC
  • 11. Johnson & Johnson Services Inc.
  • 12. Leo Pharma A/S
  • 13. Merck & Co., Inc.
  • 14. Novartis AG
  • 15. Pfizer Inc.
  • 16. Sun Pharmaceutical Industries, Inc.

LIST OF FIGURES

  • FIGURE 1. DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DERMATOLOGICAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DERMATOLOGICAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DERMATOLOGICAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DERMATOLOGICAL THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ANTI-ACNE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY HERPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ROSACEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. DERMATOLOGICAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 106. DERMATOLOGICAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023